JPM
Sector Deep-Dive Context
Only DOMINANT moat in the cohort, leading the disruption-narrative repudiation
FY26 negative operating leverage guide is now read sector-wide as late-cycle peak signaling
Best-balanced layer mix in the cohort with proprietary CIB private credit build offsetting NII compression
$30-40B excess capital is the cohort's largest acquirer firepower — being deployed entirely to buybacks
SLOOS-DRBLACBS divergence is the actively-firing late-cycle credit signal across the cohort
"JPMorgan Chase just delivered a banner year with $57.5B in net income, 20% ROTCE, and $30-40B in excess capital. But with four concurrent regulatory processes — Basel Endgame, G-SIB recalibration, credit card APR caps, and stablecoin legislation — creating a wider-than-normal outcome space, is the current valuation adequately discounting the tail risks?"
JPMorgan Chase is the largest US bank by assets at $4.4T, with the #1 retail deposit share for five consecutive years, the #1 investment banking wallet share, and $6.8T in AWM client assets. FY2025 produced record results across all four segments. The firm reports Q1 2026 earnings this week, marking the start of our banking sector coverage.
Executive Summary
Cross-lens roll-up assessment
JPMorgan Chase enters Q1 2026 as the unambiguous best-run US bank, operating at historical peak performance across all four segments. FY2025 delivered $57.5B in net income (excluding significant items), 20% ROTCE, and record revenue of $185B. The balance sheet carries $30-40B in excess capital per CEO Dimon. The competitive moat is DOMINANT, the revenue base is DURABLE, and funding fragility is MINIMAL. The forward view is unusually wide because of four simultaneous regulatory processes whose outcomes are mutually uncorrelated. The 2026 guide implies flat NII and ~9% expense growth, making negative operating leverage the base case absent upside surprise. The valuation sits at the upper end of the post-GFC range.
The business quality is unambiguously high and the operational execution is at historical peak. However, the valuation prices continuation rather than compression, the regulatory outcome space is unusually wide, and the 2026 guide implies negative operating leverage as the base case. De-escalation triggers: Basel Endgame finalization with favorable G-SIB treatment, card APR cap proposals fading without legislation, Genius Act closing the interest-on-stablecoin loophole, card NCO rate tracking below 3.3%. Escalation triggers: APR cap legislation advances, wholesale charge-offs sustained above 30bps, NBFI loss events beyond Q3 fraud instances, card NCO rate exceeding 4.0%, any material CET1 consumption event.
Key Takeaways
- •COMPETITIVE_POSITION is DOMINANT (HIGH confidence, E3) — $4.4T asset scale, #1 retail deposit share for 5 consecutive years, #1 IB wallet share at 8.9%, $6.8T AWM client assets growing 20% YoY. No US peer combines this breadth with comparable scale.
- •REVENUE_DURABILITY is DURABLE (HIGH confidence, E3) — universal bank diversification across CCB, CIB, AWM, and Corporate with FY2025 revenue of $185B and ROTCE of 20% demonstrates structural revenue durability. Card loan growth 6-7% in 2026 transitioning from cycle-driven to growth-driven.
- •FUNDING_FRAGILITY is MINIMAL (HIGH confidence, E3) — CET1 of 14.5% with $30-40B in excess capital per Dimon. SCB floored at 2.5%. Record client asset inflows of $553B FY2025.
- •REGULATORY_EXPOSURE is ELEVATED (HIGH confidence, E3) — four concurrent regulatory fronts (Basel III Endgame, G-SIB surcharge, credit card APR caps, stablecoin Genius Act) produce an outcome range from mildly favorable to 'dramatic' per Dimon.
- •EXPECTATIONS_PRICED at DEMANDING (MEDIUM confidence, E2) — ~14-15x trailing earnings and ~2.3-2.5x tangible book is at the upper end of the post-GFC range, implying continuation of favorable conditions rather than compression.
- •TAIL_RISK_SEVERITY at MODERATE (MEDIUM confidence, E2) — compound downside scenario (APR cap + stablecoin disintermediation + wholesale deterioration + conservative Basel) would compress ROTCE from ~18% toward 12-14% and consume excess capital. Probability 5-15% over 12 months.
Key Tensions
- •Exceptional execution meets demanding valuation — JPM is operating at historical peak while trading near the post-GFC valuation ceiling, narrowing margin of safety if any regulatory or execution imperfection occurs
- •2026 guidance implies negative operating leverage as the base case — flat NII of ~$95B with ~9% expense growth to ~$105B means earnings growth must come from CIB markets, fees, share count, and credit improvement
- •The $160B NBFI lending book has grown significantly over 7 years but has never been tested through a real credit cycle, and Dimon explicitly acknowledges losses would appear in a deep recession after credit enhancement erodes
Moat Mapper
Is the competitive advantage real and durable?
Key Metrics
Key FindingsClick to expand details
Signal AssessmentsClick for full context
| Signal | Scale | Assessment | Evidence |
|---|---|---|---|
Competitive Position | — | DOMINANT | 3Triangulated |
Model Debates
Cross-Lens Insights
Where Lenses Agree
- ✓JPM operates at or near historical best across all four segments — corroborated by Moat Mapper, Stress Scanner, Gravy Gauge, and Fugazi Filter
- ✓Regulatory exposure is the dominant forward risk vector — agreed by Regulatory Reader, Gravy Gauge, Stress Scanner, and Myth Meter
- ✓Capital return capacity is substantial and disciplined — agreed by Stress Scanner and Consolidation Calibrator
- ✓The valuation is at the upper end of the post-GFC range, not the middle — Myth Meter with support from Insider Investigator (absence of open-market buying)
Where Lenses Differ
REGULATORY_EXPOSURE
Both lenses agree on the severity level. Sub-component weights differ — Gravy Gauge weights credit card APR cap most heavily because it would affect core revenue economics; Regulatory Reader gives equal weight to Basel, G-SIB, APR caps, and stablecoin.
The following publicly available documents were collected and extracted into a structured fact dossier that powered this analysis.
SEC Filing
- Annual Report (10-K) — FY2025
- Quarterly Report (10-Q) — Q3 2025
- Quarterly Report (10-Q) — Q2 2025
- Quarterly Report (10-Q) — Q1 2025
- Current Reports (8-K) — 10 filings (2025-2026)
- Proxy Statement (DEFA14A) — 2026
- Form 4 Insider Transactions — 20 filings (March 2026)
- Form 144 Proposed Sales — 10 filings
Earnings Transcript
- Q4 2025 Earnings Call Transcript
- Q3 2025 Earnings Call Transcript
- Q2 2025 Earnings Call Transcript
- Q1 2025 Earnings Call Transcript
Research Document
- Congressional Trading (STOCK Act) — Quiver Quantitative
- Google Trends — JPMorgan Chase search interest